Vir Biotechnology, Inc 10-Q for FY2021 Q2
Vir Biotechnology, Inc. (VIR)
10-Q
2021-08-05
For: 2021-06-30
View Original
Added on
April 09, 2026
About this 10-Q
Vir Biotechnology, Inc filed this 10-Q on August 5, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).
Headline figures
Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $177.07M
- up 164.3% from $66.99M a year earlier
- Net income
- $61.81M
- compared with a net loss of $31.17M a year earlier
- Diluted EPS
- $0.46
- compared with -$0.27 a year earlier